Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Viale

Showing results (261-270 of 302) with videos related to

Pageof 31
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2017
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety studyS M Swain, M S Ewer, G Viale, et al.
Breast Cancer Research and Treatment|September 21, 2017
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trialG Viale, F A de Snoo, L Slaets, et al.
Histopathology|April 21, 2006
The prevalence and clinical implications of c-kit expression in plasma cell myelomaG Pruneri, M Ponzoni, A J M Ferreri, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 5, 2014
Long-term follow-up of 5262 breast cancer patients with negative sentinel node and no axillary dissection confirms low rate of axillary diseaseV Galimberti, A Manika, P Maisonneuve, et al.
Breast (Edinburgh, Scotland)|October 11, 2011
Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial designW Eiermann, J Bergh, F Cardoso, et al.
NPJ Breast Cancer|June 9, 2025
Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer preventionG Aurilio, D Serrano, M Lazzeroni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2013
Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort studyA Guerrieri-Gonzaga, M Lazzeroni, E Botteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breastG Pruneri, M Lazzeroni, V Bagnardi, et al.
Oncogene|October 24, 2007
Breast cancer metastases are molecularly distinct from their primary tumorsM Vecchi, S Confalonieri, P Nuciforo, et al.
Breast Cancer Research and Treatment|January 20, 2009
Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO)J Y Petit, U Veronesi, R Orecchia, et al.
Pageof 31

Showing results (261-270 of 302) with videos related to

Sort By:
Pageof 31
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2017
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety studyS M Swain, M S Ewer, G Viale, et al.
Breast Cancer Research and Treatment|September 21, 2017
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trialG Viale, F A de Snoo, L Slaets, et al.
Histopathology|April 21, 2006
The prevalence and clinical implications of c-kit expression in plasma cell myelomaG Pruneri, M Ponzoni, A J M Ferreri, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 5, 2014
Long-term follow-up of 5262 breast cancer patients with negative sentinel node and no axillary dissection confirms low rate of axillary diseaseV Galimberti, A Manika, P Maisonneuve, et al.
Breast (Edinburgh, Scotland)|October 11, 2011
Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial designW Eiermann, J Bergh, F Cardoso, et al.
NPJ Breast Cancer|June 9, 2025
Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer preventionG Aurilio, D Serrano, M Lazzeroni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2013
Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort studyA Guerrieri-Gonzaga, M Lazzeroni, E Botteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breastG Pruneri, M Lazzeroni, V Bagnardi, et al.
Oncogene|October 24, 2007
Breast cancer metastases are molecularly distinct from their primary tumorsM Vecchi, S Confalonieri, P Nuciforo, et al.
Breast Cancer Research and Treatment|January 20, 2009
Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO)J Y Petit, U Veronesi, R Orecchia, et al.
Pageof 31